Cargando…
Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488129/ https://www.ncbi.nlm.nih.gov/pubmed/26135890 http://dx.doi.org/10.1186/s13075-015-0681-7 |
_version_ | 1782379102063296512 |
---|---|
author | Markusse, Iris M. Lems, Willem F. Huizinga, Tom W.J. Allaart, Cornelia F. |
author_facet | Markusse, Iris M. Lems, Willem F. Huizinga, Tom W.J. Allaart, Cornelia F. |
author_sort | Markusse, Iris M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4488129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44881292015-07-03 Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply Markusse, Iris M. Lems, Willem F. Huizinga, Tom W.J. Allaart, Cornelia F. Arthritis Res Ther Letter BioMed Central 2015-07-02 2015 /pmc/articles/PMC4488129/ /pubmed/26135890 http://dx.doi.org/10.1186/s13075-015-0681-7 Text en © Markusse et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter Markusse, Iris M. Lems, Willem F. Huizinga, Tom W.J. Allaart, Cornelia F. Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply |
title | Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply |
title_full | Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply |
title_fullStr | Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply |
title_full_unstemmed | Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply |
title_short | Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply |
title_sort | response to ‘feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488129/ https://www.ncbi.nlm.nih.gov/pubmed/26135890 http://dx.doi.org/10.1186/s13075-015-0681-7 |
work_keys_str_mv | AT markusseirism responsetofeasibilityoftailoredtreatmentbasedonriskstratificationinpatientswithearlyrheumatoidarthritisauthorsreply AT lemswillemf responsetofeasibilityoftailoredtreatmentbasedonriskstratificationinpatientswithearlyrheumatoidarthritisauthorsreply AT huizingatomwj responsetofeasibilityoftailoredtreatmentbasedonriskstratificationinpatientswithearlyrheumatoidarthritisauthorsreply AT allaartcorneliaf responsetofeasibilityoftailoredtreatmentbasedonriskstratificationinpatientswithearlyrheumatoidarthritisauthorsreply |